REBusinessOnline

Bristol Myers Squibb Signs 113,000 SF Life Sciences Lease Expansion in Boston

Cambridge-Crossing

With the Bristol Myers Squibb expansion, 250 Water Street becomes the fourth science and technology building at Cambridge Crossing to be fully leased, following 222 Jacobs Street, where both Philips North America and neuroscience-focused Cerevel Therapeutics currently reside, and 350 and 450 Water Street, where Sanofi will soon consolidate much of its local workforce.

BOSTON — Bristol Myers Squibb has signed a 113,000-square-foot life sciences lease expansion at 250 Water St. at Cambridge Crossing, a 43-acre mixed-use project at the intersection of Cambridge, Somerville and Boston. The global pharmaceutical company is adding the remaining available space to its initial lease, which was announced in August of last year. Developer DivcoWest recently topped off the 480,000-square-foot building and expects to deliver it in 2022.

Content Partners
‣ Bohler
‣ Lee & Associates
‣ Lument
‣ NAI Global
‣ Walker & Dunlop

Webinars on Demand


Conferences


Subscribe to the newsletter

Read the Digital Editions

Western Multfiamily & Affordable Housing Business

Southeast Multfiamily & Affordable Housing Business

Heartland Recent Issue

Northeast Recent Issue

Southeast Recent Issue

Texas Recent Issue

Western Recent Issue

Shopping Center Business

California Centers

Student Housing Business

Seniors Housing Business

Featured Properties  

2021 Finance Insight Video Interviews